These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 10096866

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
    Magiatis P, Mitaku S, Skaltsounis AL, Tillequin F, Koch M, Pierré A, Atassi G.
    J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New antitumor agents in the acronycine series].
    Tillequin F.
    Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
    Elomri A, Skaltsounis AL, Michel S, Tillequin F, Koch M, Rolland Y, Pierré A, Atassi G.
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
    [Abstract] [Full Text] [Related]

  • 8. Preparation and configuration of racemic and optically active analgesic dialkylaminoalkylnaphthalenes.
    Ghislandi V, Azzolina O, Collina S, Paroli E, Antonilli L, Giuseppetti G, Tadini C.
    Chirality; 1994 Nov; 6(5):389-99. PubMed ID: 8068498
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
    Michel S, Gaslonde T, Tillequin F.
    Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure-activity relationships in the acronycine series.
    Michel S, Seguin E, Tillequin F.
    Curr Med Chem; 2002 Sep; 9(18):1689-700. PubMed ID: 12171551
    [Abstract] [Full Text] [Related]

  • 14. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
    Koch M.
    Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Absolute configuration of chloro-bisabolene sesquiterpene.
    Zhu Y, Yu KB, Jia ZJ.
    Pharmazie; 2004 Jul; 59(7):513-5. PubMed ID: 15296086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR, al-Baker S, Shamsuddin S, Siddik ZH.
    J Med Chem; 1997 Jan 03; 40(1):112-6. PubMed ID: 9016335
    [Abstract] [Full Text] [Related]

  • 20. Acronycine derivatives: a promising series of anticancer agents.
    Nguyen QC, Nguyen TT, Yougnia R, Gaslonde T, Dufat H, Michel S, Tillequin F.
    Anticancer Agents Med Chem; 2009 Sep 03; 9(7):804-15. PubMed ID: 19594412
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.